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Abstract
Background: Jet injectors are advantageous over needle injectors by eliminating
sharps hazards. The Government Accountability Office estimates 29%
preventable sharp injuries with an estimated direct cost of more than $500 million
out of the CDC’s reported incidence of 385,000 needle stick injuries per year
among US hospital healthcare workers. Yet the forces required to set and trigger
devices using spring mechanisms for medication delivery have not been
explored. This laboratory experiment measured forces exerted by healthcare
workers (HCWs) using a particular jet injector approved by FDA in 2011.

Objectives: In order to quantify the ergonomic impact on OCHWs using a
needle-free injector, the first objective was to evaluate the dynamic forces
required to activate the trigger injector button and the reset station for the
injector, with their respective means, for each of the parameters studied. The
second objective was to compare these forces to those required to use four
previously analyzed retractable intramuscular syringes with needles. Finally, the
third objective was to assess potential psychophysics ergonomic impact on
OHCWs with use of these devices to formulate future design changes and
recommendations for manufacturers and HCWs, respectively.
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Methods: This laboratory experiment was conducted through a multi-disciplinary
team approach. It included a total of 136 trials (10 validation trials, 116
experimental trials and 10 padded trials for soft tissue simulation), which were
conducted using the PharmaJet™ Injector. A force gauge and a load cell were
integrated into the triggering setup and reset station, correspondingly, enabling
force measurements to be obtained directly from the human-machine interfaces.
These force data allowed for observations of force profiles in time by the
healthcare worker as researcher while preparing for and administering injections.
Data collection used three software applications for force conversions and data
manipulation. Data were analyzed using descriptive statistics and analytical
results by using ANOVA for the trigger injector & reset station with multiple
comparison tests for parametric and non-parametric distributions, respectively.

Results: The descriptive results indicated an average force for triggering the
injector in the 116 trials was 15.92 lbs. (70.8 N) with a range of 9.77-26.46 lbs.
(43.46-117.69 N). The measured forces for the reset station ranged from 5.3582.78 lbs. (5.35-368.22 N) with an average of 25.32 lbs. (112.62 N) (SD 12.36).
Spurious findings presented with tensile forces to fill the syringes resulting in
hand strain in the first metacarpal joint after repetitive pinprick motion. The
analytical results showed an ANOVA for trigger injector with a parametric-normal
distribution with an F (2,133) Ratio 10.0472, p- value (F) 0.0001<0.05, showing
statistical significance and with a Tukey’s comparison test showing a significant
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difference in between the means of the padded trials vs. the validation &
experimental trial groups. The ANOVA for the reset station showed a Kruskal
Wallis H-statistic of 0.2568, p-value (H) 0.8795>0.05 presenting NO statistical
significance with a Dunn’s comparison test confirming NO difference in between
the medians or mean ranks of all three groups.

Conclusions: Triggering the injector and resetting the station required
considerable effort in comparison to activating 4 retractable intramuscular
syringes with needles from our previous studies, the range of mean forces were
3.63-17 lbs (16.19-77.53 N) for those syringes with the trigger injector maximum
voluntary force of 71 N being above the recommend 56.6 N.
The jet injector required more force per effort than 2 (4.4x) syringes &
similar to other 2 syringes (0.9x) previously tested when considering the
compression forces related with the trigger injector.
Additional vector forces (displacement & gripping of reset station) could
increase the cumulative effort affecting different musculoskeletal components
when the whole components of the procedure are taken into account.
Suggestions for the manufacturer regarding design changes to facilitate
HCWs’ use of this device are warranted, since some of the summation forces
during the 12 mini-steps could be avoided to achieve a higher efficiency. This
information may be useful for health care facilities when choosing devices to
protect their workers from ergonomic injuries.

vii

Application: The information might be useful for future research to achieve
accurate predictions of maximal acceptable efforts for repetitive motion tasks
when integrating all cumulative force components of a duty cycle for 8-hour work
tasks to establish tolerance limit values. Implications and future research will be
leakage of fluids while loading the syringe; fluid in the cap and immediate vicinitysplatter of body fluids or live vaccines; recommended personal protective
equipment (PPE) for potential wet shots and splatter; effect of compression and
tensile forces with viscous solutions and measurement of dynamic forces with
analytical multiple-sensor gloves.
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Chapter I
Introduction
Needle-free injector devices (NFIDs) are engineered devices used to
deliver a liquid medication by the intramuscular (IM) or subcutaneous (SC) route
with a pressure jet stream that is an alternative to conventional needle syringes.
Jet injectors are potentially advantageous over needle syringes in employee
safety by eliminating sharps and waste disposal. Studies reveal potential
advantages for the patient safety, vaccine efficacy, compliance, relative overall
comparative cost, reduced psychological stress, reduced pain, lower vaccine
volume, antigenic dispersion, elimination of broken needles, reduction of
accidental needle stick injuries and occupational preference regarding use of
NFIDs over safety engineered needle devices versus the disadvantages of
higher start-up cost, higher cost against traditional needle syringes, and higher
requirements for training and maintenance of equipment (Christopher 2008;
Morrison, 2009; Brito 2010; Weniger, 2005). In spite of much scientific evidence
favoring NFIDs’ use, the ergonomic forces required for setting and triggering the
injector devices exerted by occupational healthcare workers (HCWs) using jet
spring mechanisms for liquid medication delivery have not been explored.
Measurement of dynamic forces can be expressed in Newtons (N) and pounds
(lbs.) exerted by HCWs using a particular jet injector for quantifying the human
factor impact on healthcare workers when using NFIDs.
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NFIDs are mainly beneficial over needle injectors by eliminating sharps hazards
along with compliance of 1991 OSHA standards for Blood Borne Pathogens, by
reducing transmission of Hepatitis B & C and HIV, among many others blood
borne diseases (Plog, 1973). The U.S. Government Accountability Office (GAO)
estimates 29% preventable sharp injuries by using safety engineering needle
devices and NFIDs. GAO and the U.S. Centers for Disease Control and
Prevention (CDC) estimated direct costs that supersede $500 million. This is
without taking into consideration the indirect costs related long term treatment
resulting from infectious disease transmission through blood borne pathogens
such as Hepatitis B &C and HIV, worker’s compensation system & disability,
laborer absenteeism and other psychological implications (Saia, 2010).

The

CDC reported an incidence of 385,000 needle-stick and sharp injuries among
hospital-based

U.S.

healthcare

workers

(HCWs),

without

taking

into

consideration other healthcare settings that approximate the number of cases to
800,000 injuries overall for the nation per year (Saia, 2010; Panlilio, 2000; Henry,
1995; Haiduven, 2006).
NFIDs have been available for humans since the 1930s and used
extensively for mass vaccination over a period of five decades for programs of
smallpox, polio, and measles. Historically the devices have been gas, spring or
electrically powered. NFIDs are reemerging after being put aside for a few
decades with FDA fomenting the use of spring powered technology (Reis, 1998;
Hingson, 1963; Christopher 2008). According to the Defense Logistics Agency
(1997) on chapter 2 of the biological defense program, the U.S. military realm
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had some historic concerns with contamination avoidance and individual
protection with lacerations and cross contamination regarding re-use of injector
systems leaving some caveats and paradigms with the use of this technology in
the past. With today’s revamping technology with spring-powered regulated
injection systems, which penetrate the skin for IM or SC medication
administration in less than 1/3 of a second, PharmaJet™ needle-free devices
and other injectors eliminate needle re-use and cross-contamination between
patients. The polycarbonate cylinder is a sterile, single use with auto-disabling
properties and minimization of hazardous waste eliminate the aforementioned
risk hazards (Morris, 2009). Safety and effectiveness with Flu vaccines and other
potential hazards has been a restraint for many needle-free injector
manufacturers to release their products in today’s market, even though the
PharmaJet™ needle-free device was approved by the Federal Food and Drug
Administration in 2011 (Hartman, 2011). A few recent manufacturers, scientific
and clinical studies have been done regarding benefits of immunization with
safety engineered needles and needle-free injectors to overall effectiveness,
efficacy and efficiency of such devices from a patient and occupational safety
perspective based on the 2011 World Health Organization (WHO) global vaccine
safety Blueprints (Amarasinghe, 2012), while others are comparing the
occupational time efficiency in between both methods in humans and animal
populations (Morris, 2009; Christopher 2008). Evaluating the forces required to
activate the trigger injector button and the reset station for the injector, with their
respective means, for each of the parameters studied, attained our first objective.
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Comparing forces required between NFIDs to the use of safetyengineered needles with retractable intramuscular syringes with needles was our
second objective. Since 1984, there are more than a thousand patents related
with safety devices with approximately 25 different designs (Ippolito, 1997;
Haiduven, 2006). Several generations of such devices, coined “devices with
engineered sharps injury protection” or (ESIP) have been established, but for
practical reasons there are 4 generations. The first generation comprises
syringes with sheaths that slide frontward after usage. The second generation
consists of accessories snapped into the needle. The third generation has
retractable needle mechanisms, which retract while still in the patient’s soft
tissues (Haiduven, 2006). The forth generation will be described as the reemerging NFIDs with spring-powered technologies. Even though the mechanism
involved for operating these devices might be technically different, comparisons
can be attained with previous studies comparing the compressive forces utilized
while injecting saline into simulated patient material (SPM). The category 3
studies showed a range of saline injection on SPM for compressive force
experiments in between 16 and 77 N, with an average of 57 N or 13 lbs. The kind
of the design for category 3 and category 4 devices is to elude reuse (Haiduven,
2006 & 2010). Dynamic force gauge measurement of compressive forces will be
utilized to measure forces in N and lbs for the trigger injector button of the NFIDs
for category 4 devices.
One of the challenges of human factors engineering is to evaluate
different workplace demands and contrast them to their functional capacities at
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work to establish tolerance limit values (TLV). The potential psychophysics
impact on ergonomic impact on HCWs with use of NFIDs has to be analyzed to
create an appropriate tool that would avoid damage to the HCWs during and
after the utilization of the tool with repetitive motion (Potvin, 2012). In order to
formulate future design changes and recommendations for manufacturers and
HCWs, respectively, we need to understand some basic concepts of ergonomics,
to ensure safe and productive activities within the workplace while using the tools
(LaDou, 2004), especially the ones related with psychophysics to predict the
maximum acceptable efforts (MAE) for repetitive tasks for an 8-hr workday, while
using the duty cycle (DC), which is the total effort duration divided by the cycle
time. By using the Potvin equation and principals, which go, beyond the scope of
detailing for this specific project, the maximal acceptable efforts can be obtained
as a percentage of the single maximal voluntary effort (MVE), which are
multiplied by the DC. The resultant equation after detailed meta-analysis results
in the simplified formula 1:
MAE= 1- DC (0.24)

Formula 1

(Potvin, 2012)

The resultant equation describes a strong negative exponential relationship
between DC and MAE. This relationship shows a rapid decline in MAE at low
DCs with a slow decrease as DC increased to higher values. The advantage of
using the equation consists in estimating the absolute magnitude of MAE without
specific previous published data. Once MAE is calculated, you can determine the
maximal average force (MAF) by multiplying MAE by the recommended MVE
(rec MVE) (see formula 2).
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Formula2

MAF= MAE x rec MVE

(Potvin, 2013)

In this case, we can extract previous published information from Potvin’s
equation studies and NASA’s ergonomic human performance capabilities and
forces for the hand and thumb-finger strength. The first author describes the
MVEs for the pulp pinch push and finger tip push to be 58.8 N (13.21 Lbs.) and
56.6 N (12.72 lbs.), respectively. This will apply to the study related with the
trigger injector button. Other studies relating right-thumb pinch forces are more
conservative and use an injury threshold of 10 N (2.24 lbs.) but involve prolonged
pushing actions (Shergill, 2009). MAE results were 35 Nm at a low frequency of 2
per minute at the recommended 56.6 Newtons for finger tip push (Potvin, 2013),
which is relevant when taking into consideration that the fastest rate for an HCW
might be 2 per minute if it takes 30 seconds to give the NFIDs shot (Morrison,
2009). NASA STD-3000 203 describes the thumb-finger tip strength with a limit
of 58 Newton’s (13 lbs.) for brief hold and 35 N (8 lbs.) for sustained hold (2008).
The MVF for the pushing down a hose is 130.2 N, which is a similar motion when
comparing the activation of the reset station (Adrews, 2008; Potvin, 2006). All of
the values are taking into consideration a neutral wrist position. The need for
recuperation time increases exponentially with effort duration (Rohmert, 1973).
Long prolonged efforts, even if low forces are applied increase the risk for muscle
pain and injury (Veiersted, 1993). Taking into consideration that an 8-hour shift
has 480 minutes, it is not recommended to go above this level even at a
frequency of 1 per minute for most repetitive activities without taking into
consideration the force measurements. The Potvin equation is good for isolated
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tasks, but a caveat arises when entirely combined activities like triggering injector
button press, resetting station and other tensile forces for loading syringes come
into play. The Potvin equation is suitable with a conventional task with similar
features for the 75th percentile of the female exertion forces (2011). Studies
relating monotonous work with physical factors such as force, repetitive motion
and anatomical position related preponderance of force over the other two,
showing increasing levels of incidence of hand pain and tendonitis. Studies
showing repetitive work are less consistent of hand injury, even though they are
always

reasonable

(Thomsen,

2013).

Anatomical

position

has

less

predominance, even though neutral anatomical position was utilized in the
present project (Thomsen, 2013).
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Chapter II
Specific Objectives and Hypothesis
Specific Objectives
1. The first objective was to evaluate the dynamic forces required to activate
the trigger injector button and the reset station for the injector for the
NFID-category 4 device, with their respective means, for each of the
parameters studied.
2. The second objective was to compare these forces to those required to
use four previously analyzed retractable intramuscular syringes at the VA
lab with needles- category 3 devices.
3. The third objective was to assess potential psychophysics ergonomic
impact on HCWs with use of these devices to formulate future intervention
design changes and recommendations for manufacturers and HCWs,
respectively.
Hypothesis
1. The Ho null hypothesis for the trigger injector was that there is no
difference in between the three means of force measurements by using Fstatistics:
Null Hypothesis: Trigger Injector
Ho: the means of measured forces (lbs or Newton’s) are all equal
H0: µ =1, µ =2, µ =3
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df=2

2. The Ho or null hypothesis for the reset station was analyzed to compare
the medians in between each three sets of groups by using the Hstatistics:
Null hypothesis: Reset Station
Ho: the medians of measured forces (lbs or Newton’s) are all equal
H0: M=1, M =2, M =3

(Mean Ranks or Medians)
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Chapter III
Materials and Methods
Support for materials and facilities: This research was funded & supported by
the NIOSH SERC- COPH-USF, Department of Environmental & Occupational
Health & in part is based upon work supported by the USF-COPH Department of
Global Health & Office of Research & Development, Department of Veterans
Affairs (DVA), Tampa FL. Conducted by multi-disciplinary team: Occupational
Medicine, Infection Control, Mechanical & Biomedical engineers. Research
team: H. Olivero Lara, MD USF OMR resident; and employees of DVA
P. Ramaiah, MSBME; D. Haiduven, PhD; & M. Kerrigan, MSBME. Other
collaborators are mentioned in the acknowledgement (left to right Figure 1).

*Photo by VA multi-disciplinary team
Figure 1. Multi-disciplinary team researchers at VAD facility
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Materials
One commercially available NFID, approved by FDA in 2011, was utilized
for the experiment. The aforesaid device is the Stratis PharmaJet

TM

System

Needle-free injector device, which is composed of an injector, reset station,
needleless syringe and filling adaptor (see figure 2. Read L to R).

*Photo by VA multi-disciplinary team with permission of manufacturer (L to R)
Figure 2. Components of the Stratis PharmaJet TM NFIDs

The device works by injecting a liquid under pressure by a spring powered
technology, which uses a blue tipped safety feature that avoids misfiring if the
device is not aligned perpendicular to the skin with concomitant synchronous
pressure applied. Other safety features include a polycarbonate syringe for single
use, that cracks without expelling fragments to the surroundings when air
contents in the form of bubbles are within the cylinder of the syringe, described
by the prior manufacturer as a “wet shot”. (PharmaJetTM, Colorado, U.S.A.).
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One hundred and thirty-six needleless syringes were prefilled with saline
solution, consisting up bacteriostatic 0.9% sodium chloride injection, USP, 30
mL. Liquid was drawn with the needleless syringe by using the filling adapter
shown in the right lower corner of figure 2.
Other important materials consist of a laptop, HP Pavilion entertainment
notebook PC, with an operating system of Microsoft 7 with 64 bits; a load sensor
with PCB piezotronics, model 260A02, three component force sensor; a signal
conditioner, PCB piezotronic, model 480B, with three channel 1 CP sensor signal
conditioners (see Figure 3).

*Photo by VA multi-disciplinary team
Figure 3. Instruments utilized to measure forces

Additional materials include a digital force gauge by COM-TEN (Com Ten
Industries, Pinellas Park, Florida) Andilog technology Stentor II, which draws
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curves vs. travel, with incorporation of force gauge sensors with internal sensor
up to 100 N and an accuracy of 0.01N.
Other materials include: ductless fume hood from Sentry systems (Sentry
Air Systems, Inc., Houston, TX) thermometer, for room temperature variations
(Figure 4); disposable gloves; a holding bin, to hold the prefilled syringes; waste
bin, to hold the used syringes after firing; safety goggles, to protect against
inadvertent exposure to solutions or moving parts; a wide base metal stand and
ante-cubital fossa simulation pad (ACF PAD) for tissue simulation of injection
(see Figure 5) (Limbs & Things, Savannah, GA); a communications cable, three
USB two RS-232 DB 9/DB-25 serial adapter; the cable; data-transfer software for
force gauge to laptop called termite terminal emulator software; a data transfer

*Photo by VA multi-disciplinary team
Figure 4. Safety ductless fume hood and thermometers
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from load to sensor on reset station to the laptop, which consists of Lab VIEW
software from National Instruments (National Instruments, Austin, TX) (Figure 6.);
a metal stand with a wooden sockets inside straps, to hold injector and force
gauge for each trial; a stylus to tare the force gauge; and a wooden ruler, to set
the position for the rotating handle on the force gauge.
In addition, a level, adhesive labels, and heavy utility gloves to wear while
bracing the ACF pad against the tip of the syringe for safety purposes (see
Figure 5), a non-slip mesh liner, a microfiber towel, compressed air can,
clipboard and waste basket were materials used for the elaboration of the
experiment.

*Photo by VA multi-disciplinary team
Figure 5. Ante-cubital fossa simulation pad (ACF Pad) and normal saline
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*Photo by VA multi-disciplinary team
Figure 6. Reset station with load sensor adhered on surface

Procedures
The following experiment was conducted by using a rigorous protocol of
force measurements for the Pharm jet TM injector that is described in full detail as
part of the annex A for this laboratory research study. It portrays all the materials,
activities performed, protocols for pre-trial activities, which include the set-up of
the reset station equipment and the force gauge equipment. It displays the force
gauge settings set with the Termite software™ (Hernel Hempstead, UK), which
occurred pre-experiment. Description of the protocol activities while running the
trials, which consist of a rigorous 94-step protocol developed for conducting trials
to avoid variability. Activities for the experiment trials were done by having three
personnel labeled as R1, R2 and R3. R1 activities consists mainly of handling all
technological software and computer activities, from a spectrum of setting to
analyzing the data, R2 activities are mainly described as the executing and
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reporting trials for all measured activities, and R3 main role is recording and
supervising all activities followed in chronological order.
A total of 136 total trials were conducted using the PharmaJet™ Injector
(10 validation, 116 trials, & 10 trials with padding) for both the trigger injector
button and the reset station, follow-up by a 94-step protocol developed for
conducting trials to avoid variability with repeat step description for additional
trials (Annex A).
A force gauge and load cell was integrated into the triggering setup &
reset station, respectively, enabling force measurements to be obtained directly
from the human-machine interfaces (See Figure 7 a & b).

*Photo by VA multi-disciplinary team
Figure 7. a & b) Trigger injector setup & Reset station setup
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Data collection used 4 software applications for force conversions & data
manipulation, which include Termite Terminal Emulator software (Hernel
Hempstead, UK), Lab View software from National Instruments (Austing, TX,
U.S.A), Mat lab (Natick, Massachusetts, U.S.A.) and Excel spreadsheets
(Redmond, WA, U.S.A.)(See figure 8 a & b and Figure 9 a & b).

*Photo by VA multi-disciplinary team
Figure 8. a & b) Injector mount for deactivation of safety tip

The injector mount consists of a milled-out wooden block which defeats the
safety tip for the trigger injector device and the researcher uses a hand lever to
activate the injector in which the force is detected by the manual force gauge with
an RS232 interfacing through the Termite software application (Figure 8 a & b).
The experimental set up for force measurement of the reset station
consists of a load sensor adhered to the arm of the reset station with a sample
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rate of 1,000/second for duration of 7 seconds, with subsequent data collection to
a laptop by using a USB port to Lab View Software (Figure 9 a & b).
Floor markings were used on the floor with the shape of two “WW”. That
way the operator will have less room for variation with the lower stance that
indirectly affects the trunk and upper body position (Figure 10).

*Photo by VA multi-disciplinary team

Figure 9. a & b) Reset station force measurements and data collection
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Figure 10. Markings on the floor-determining stance of R2 operator

Methods
This work consisted of an investigational experimental project for product
evaluation of technological development with an interventional aim towards future
manufacturing designs and practices towards HCWs. The research consisted of
the product evaluation of the NFIDs Stratis manufactured by PharmaJet TMcategory 4 devices. During the time the project protocol plans commenced late
2011, it was the only product that was approved by FDA in the market that
allowed the bench testing of the product as well. Another manufacturer was
getting clearance at that time, but was not allowing the product to be tested.
That is why the product was not compared to similar products of its kind
(category 4) for its use and the objectives generated were very specific to allow
measurements of the device, compare the measurements with previously studied
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category 3 devices in the VAD lab, and future interventional aims towards the
ergonomically designed NFIDs regarding utilization for HCWs.

Study design and population: The project entailed of an experimental
prospective cohort study design that studied three different groups of trials with
similar effort-conditions across time with an expected outcome measurement of
dynamic forces for both trigger injector button and reset station for the NFID. A
total of 136 total trials were conducted using the PharmaJet™ Injector. The
experiment consisted of 10 validation trials, 116 experimental trials, and 10 trials
with padding simulation for both the trigger injector button and the reset station.

Variables: Those that might come into consideration for the reproducibility of the
study will be age, gender, body constitution of operator, precision of measuring
devices, smoking habits, educational level, maturation of operator, padding finger
simulation, prior health conditions and injuries. In order to control threats for
internal variability, three researchers, R1, R2 and R3 were involved in the
experiment. R1 ran the software applications for all operations involved and R3
supervised both R1 and R2 step-by-step operations. A single R2 operator
executed all 136 trials. A protocol consisting of 94-steps was created to promote
repeatability for the trials and reproducibility for future comparison studies;
maturation of operator was taken into consideration as part of the validation trial
group and differentiated from the experimental group (Annex A).
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The idea was to come close to a summation equation of dynamic forces for the
revamping technology involving the device. Since several steps could potentially
be excluded, several criteria where taken into consideration.

During the

procedure we only measured the trigger injector forces and reset station forces
with only one operator R2 doing all the sampling execution to avoid additional
interpersonal variability. Excluded criteria included measurement of tensile forces
related with the filling of the needless syringes due to the potential for the user of
buying prefilled syringes, displacement forces while gripping, and different users
during the operation of the device. Even though the excluded criteria might affect
the overall summation of forces, annotations were done with detail by R3
regarding any discomfort or pain while filling the needleless syringes with saline
reported as spurious findings.

Timing and setting: The protocol was elaborated during the first monthly quarter
of 2012, and the experimental project preparation was in April 2012. The actual
research was done during the month of June 2012. Subsequently, software
analysis and tabulation of data with further statistical analysis was done. The
experiment took place in the Department of Veterans Affairs (DVA) Research
Center of Excellence in Tampa, Florida. The Product Evaluation Laboratory,
directed by Donna Haiduven, PhD, RN, CIC. was funded by the DVA
Occupational Health Strategic Healthcare Group in the Office of Public Health.
This laboratory, using simulated patient materials, has as its initial charge,
evaluation of devices with engineered sharps injury protection.
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Short training of use of device was provided by manufacturer, which is also found
on the web site for future inquires. There were no financial relationships with
commercial interests between the manufacturer and the research team.

Data collection: A force gauge and load cell was integrated into the triggering
setup & reset station, enabling force measurements to be obtained directly from
the human-machine interfaces. Data collection used 4 software applications for
force conversions & data manipulation. All the information was finally stored in
the Excel database for simplicity of further use. Observations of specific events
were annotated in paper with timing for each of the experimental trials.

Statistical Analysis: For simplicity of understanding, the results were divided
into descriptive statistics and analytical statistics. The first part of the study
consisted of graph tracings displayed to obtain clear pattern of force vs. time
(effort across time or sample rate) for the trigger injector and the reset station.
Several tables demonstrating the average force, minimum force, maximum force,
standard deviation and range were obtained for the three group sets of data
described as validation trials (n=10), experimental trials (n=116), and trials with
padding simulation (n=10) with their respective trigger injector button and reset
station. Values obtained will be recorded and compared to literature standards
and subsequently, compared to 4 previously studied category 3-syringe devices
from the VAD previous studies.
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The second part of the study consists of analytical study in which
validation trials (n=10), experimental trials (n=116), and trials with padding
simulation (n=10) with their respective trigger injector button and reset station are
analyzed to compare the means in between each three sets of groups for the
trigger injector and mean ranks or medians for the reset station. For this part,
Excel spreadsheets were used as database and the information was analyzed by
using the Prism 6 Statistical Software, 2013. For the trigger injection button a
one-way ANOVA was utilized to compare the means for forces in pounds of the
three different groups of trials. Since the study is not comparing two different
injector devices, the comparison was done in between the three abovementioned
trials. The validation and the experimental trials are easy to understand, but the
padded simulation trials were done to notice any differences with the curves of
force vs. timed effort-sample rate obtained to analyze any benefit by adding a
soft tissue that will simulate the tip of the finger fat pad simulating the humanmachine interference. An ACF padding simulating soft tissue was used for this
purpose.
The Ho or null hypothesis was that there is no difference in between the
three means of force measurements by using F-statistics, known as the one-way
analysis of variance. µ =1, µ =2, µ =3 were representing the validation trial,
experimental trials and trials with padding simulation force means that were
compared in pounds, respectively. In addition, the valued were also given in
Newtons to provide adequate comparisons with prior studies:
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Null hypothesis: Trigger Injector Button
Ho: the means of measured forces (lbs or Newton’s) are all equal
H0: µ =1, µ =2, µ =3

(Means)

Analytical studies were also done for the reset station by using nonparametric one-way ANOVA Kruskal-Wallis. Data was tested for normality and
converted to logarithmic values.

The reset station validation trials (n=10),

experimental trials (n=116), and trials with padding simulation (n=10) were
analyzed to compare the medians in between each three sets of groups by using
the H-statistics:

Null hypothesis: Reset Station
Ho: the medians of measured forces (lbs or Newton’s) are all equal
H0: M=1, M =2, M =3

(Mean Ranks or Medians)

Multiple comparison tests were performed on both trigger injector and
reset station to notice group differences. The data was finally compared to
previous recommended limit values and analyzed by comparing it to the
ergonomic equations that are in use for finger and arm measurement forces,
particularly to the current recommended ergonomic values and Potvin’s equation
for repetitive motion equations to develop future suggestions for manufacturers
and HCWs recommendations.
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Ethical considerations: In spite of the fact that it was mainly a product
evaluation under controlled laboratory conditions, the ethical standards and
training were highly taken into consideration prior starting the analysis, by
following requirements for the VA IRB and USF-NIOSH ERC to maintain
excellence in research standards. The research project, which this experiment
was part of, received approval from the VA Office of Research & Development,
Protocol #006142, “Laboratory Evaluation of Sharps Devices to Prevent Blood
Exposures and Ergonomic Injuries in Healthcare Workers.”
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Chapter IV
Results
The results presented in this experimental investigational project for
product evaluation will be presented in sequence with the established objectives
in matter. For ease of interpretation, the results were divided into descriptive
statistics and analytical statistics.
Results for Descriptive Statistics
In the descriptive statistics, the compressive force experiments were
analyzed in a series of 136 graphs in an Excel spreadsheet for the trigger injector
and for the reset station. Figure 11 displays a single graph for the
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Sample Rate

Figure 11. Trigger injector single data trial of sample rate (1000/sec)
Vs. Dynamic force (lbs.)
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trigger injector that was randomly picked showing a sample rate of the x-axis
across time vs. the dynamic force on the Y- axis. The graph shows three peak
spikes and an acute slump after the second spike. The sample rate was set at
1000 Hz and the measured forces in pounds. All graphs analyzed had a similar
pattern with slight variations in between each other.
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sample rate

Figure 12. Reset station single data trial of sample rate
(1,000/sec * 7 seconds) Vs. Dynamic force (lbs.)

In Figure 12, there is a graph representing a typical tracing of a reset
station in between a sample rate of 1000 Hz during a total period of seven
seconds vs. force measured in pounds. There is some interference in the first
part of the tracing and then a sudden up-rise of the slope with a variable peak
followed by a sudden decrease in the force until it plateaus to zero. The areas

27

under the curve will be representative for the total workload exerted by the
individual without taking into account the initial artifact. A picture displays the
force vector that was summarized as a dynamic force across time.
To evaluate the PharmaJet™ Needle-free trigger injector button and the reset
station, with their respective means, for each of the parameters studied the
results were tabulated exhibiting the average force, minimum force, maximum
force, standard deviation and range.

The average force for the 10 validation trials for the trigger injector was 16.29 lbs
(72.2 N) with a standard deviation of 5.78 lbs. (25 N) and a range of 9.69 -28.17
lbs. (43.25 – 125.75 Newton’s) (See table 1). The average force for the 116
experimental trials for the trigger injector was 15.92 lbs (71.07 N) with a standard
deviation of 5.78 lbs. (25.8 N) and a range of 9.77 -26.46 lbs. (43.61- 118.12
Newton’s) (See table 3). The average force for the 10 padding simulation trials
for the trigger injector was 21.84 lbs (97.5 N) with a standard deviation of 6.74
lbs. (30.08 N) and a range of 11.74 -33.17 lbs. (52.41- 148.08 Newton’s) (See
table 5).
The average force for the 10 validation trials for the reset station was
23.10 lbs (103.25 N) with a standard deviation of 6.95 lbs. (31.02 N) and a range
of 11.94 -33.36 lbs. (53.3 – 148.92 Newton’s) (See table 2). The average force
for the 116 experimental trials for the reset station was 25.32 (113.03 N) with a
standard deviation of 12.36 lbs. (55.17 N) and a range of 5.35 -82.78 lbs. (23.88369.55 Newton’s) (See table 4). The average force for the 10 padding simulation
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trials for the reset station was 22.03 (98.34 N) with a standard deviation of 8.02
lbs. (35.80 N) and a range of 10.29-32.94 lbs. (45.93- 147.05 Newton’s) (See
table 6).

Table 1.

Descriptive data for validation trials (n=10) for trigger injector
applied force measured in pounds

Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

16.29

9.69

28.17

5.78

Range

18.48

Average, minimum, maximum, standard deviation and range of forces in pounds
were described in Tables 1 through 6.

Table 2. Descriptive data for validation trials (n=10) for reset station
applied force measured in pounds
Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

23.10

11.94

33.36

6.95

29

Range

21.41

Table 3.

Descriptive data for experimental trials (n=116) for trigger
injector applied force measured in pounds

Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

15.92

9.77

26.46

3.51

Table 4

Range

16.69

Descriptive data for experimental trials (n=116) for reset station
applied force measured in pounds

Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

25.32

5.35

82.78

12.36

Table 5

Range

77.43

Descriptive data for padding simulation trials (n=10) for trigger
injector applied force measured in pounds

Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

21.84

11.74

33.17

6.74

30

Range

21.43

Table 6

Descriptive data for padding simulation trials (n=10) for reset
station applied force measured in pounds

Average

Minimum

Maximum

Standard

Force

Force

Force

Deviation

22.03

10.29

32.94

8.02

Range

22.65

Spurious findings: The tensile forces to fill the syringes were not measured in
this experiment with a tensile force gauge device, but observational recording
showed an increase of pain and hand strain in both R1 and R2 subjects while
filling the syringes with normal saline after approximately 50 consecutive syringe
fills. Pain was notorious in the 1st Metacarpal joint and first dorsal compartment
while doing repetitive pinprick motion when the normal saline was extracted by
pulling the emboli of the syringe that had a round flat surface.

Results for analytical statistics for trigger Injector
The results for the analytical statistics were presented as a series of tables
and figures by distinguishing the statistical analysis ANOVA for the Trigger
Injector for parametric data and the ANOVA Kruskal Wallis Reset Station for nonparametric data, by comparing the validation trials (n=10), the experimental trials
(n=116) and the padding simulation trials (n=10). All of the comparisons
presented in the tables are in pounds (lbs.).
.
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The one-way ANOVA for the trigger injector are described in Table 7 with
their means and medians with standard deviations. Additional information
displays confidence intervals for the three groups of trials.

Table

7

Descriptive
Statistic

One Way ANOVA – for Trigger Injector (TI)
Descriptive Statistics
Trigger InjectorTrigger Injector Trigger Injector Validation (lbs)
Experimental
Padded (lbs)
(lbs.)

Number of values
Minimum
25% Percentile
Median
75% Percentile
Maximum
Mean
Std. Deviation
Std. Error of Mean
Lower 95% CI of mean
Upper 95% CI of mean
95% CI of median
Actual confidence level
Lower confidence limit
Upper confidence limit

Validation Experimental
10
116
9.690
9.770
13.14
13.20
13.97
16.18
18.88
18.14
28.17
26.46
16.30
15.93
5.780
3.516
1.828
0.3264
12.16
15.28
20.43
16.58
97.85%
11.99
24.75

96.77%
15.55
17.00

Padded
10
11.74
16.97
20.56
27.87
33.17
21.84
6.742
2.132
17.02
26.67
97.85%
16.68
31.24

The p- value summary for the trigger injector data is shown on table 8,
with results consistent with an F ratio of 10.05 with a significant p-value below
0.0001 with significant differences among the mean values while using 2,133
degrees of freedom, with a total of three treatment columns and 136 number of
total values.
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Table 8

One Way ANOVA– P-Value Summary
Parametric ANOVA for Trigger Injector (TI)

Table Analyzed

One-way ANOVA data

ANOVA summary
F
10.05
P value
< 0.0001
P value summary
****
Are differences among means statistically significant?
(P < 0.05)
Yes
R square
0.1313
F (DFn,
ANOVA table
SS
DF
MS
DFd) P value
Treatment
(between
F (2, 133) =
P<
columns)
322.0
2
161.0
10.05 0.0001
Residual (within
columns)
2131
133
16.03
Total
2453
135
Data summary
Number of treatments (columns)
Number of values (total)

3
136

The results on Table 9 for the trigger injector consisted of normality tests to
assess the distribution of the data. By using D'Agostino & Pearson omnibus,
Shapiro-Wilk normality test and Kolmogorov Smirnoff we saw normality in 2 out
of 3 tests with an alpha set at 0.05. That allowed us to proceed with the one-way
ANOVA tests, meaning that the data were normally distributed with a similar
Gaussian distribution. From the normality tests, the D’Agostino & Pearson
Omnibus test and the Kolmogorov Smirnoff passed the normality test in
comparison to Shapiro-Wilk normality test.
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Table 9

One Way ANOVA – Normality Test for Trigger Injector

Column
Statistics

Trigger InjectorTrigger InjectorTrigger InjectorValidation (lbs)
Experimental (lbs)
Padded (lbs)
Validation
Experimental
Padded

Mean
Std. Deviation
Std. Error of Mean

16.30
5.780
1.828

D'Agostino & Pearson omnibus
normality test
K2
P value
Passed normality test (alpha=0.05)?
P value summary
Shapiro-Wilk normality test
W
P value
Passed normality test (alpha=0.05)?
P value summary
KS normality test
KS distance
P value
Passed normality test (alpha=0.05)?
P value summary

15.93
3.516
0.3264

21.84
6.742
2.132

4.487
0.1061
Yes
ns

1.650
0.4383
Yes
ns

0.5706
0.7518
Yes
ns

0.8373
0.0410
No
*

0.9716
0.0145
No
*

0.9496
0.6632
Yes
ns

0.2570
0.0600
Yes
ns

0.06492
0.2000
Yes
ns

0.1665
0.2000
Yes
ns

On table 10, a one-way ANOVA with Tukey’s multiple comparison tests for
means of the force outcomes obtained showed a significant difference between
the simulated padded trials vs. the validation and experimental trial. A trigger
injector (TI) padded trials vs. TI validation trials p-value less than 0.0067; a TI
padded trials vs. TI validation trials less than 0.0001; and a compared to TI
experimental trials vs. TI validation trials p-value above 0.9584. The means were
greater by almost 6 lbs (27 N) for the padded simulation trials.
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Table 10

One Way ANOVA – Multiple Comparisons of Means
Parametric ANOVA for Trigger Injector (TI)

Tukey’s Multiple Comparison Test and Test Details
Number of families
Number of comparisons per
family
Alpha
Tukey's multiple
comparisons test
TI- Experimental (lbs) vs. TIValidation (lbs)
TI- Padded (lbs) vs. TIValidation (lbs)
TI- Padded (lbs) vs. TIExperimental (lbs)
Test details
TI- Experimental (lbs) vs. TIValidation (lbs)
TI- Padded (lbs) vs. TIValidation (lbs)
TI- Padded (lbs) vs. TIExperimental (lbs)

1
3
0.05
Mean 95% CI of Signific Summ Adjusted P
Diff.
diff.
ant?
ary
Value
-3.494 to
-0.3663
2.761
No
ns
0.9584
1.304 to
5.547
9.790
Yes
**
0.0067
2.786 to
5.913
9.041
Yes
****
< 0.0001
Mean SE of
Mean 1
Mean 2
Diff.
diff.
n1
15.93

16.30 -0.3663 1.319

116

21.84

16.30

5.547 1.790

10

21.84

15.93

5.913 1.319

10

In Figures 13 & 14 there is a graph representing the force with standard deviation
for each of the three groups with, and a comparison of the means and 95%
confidence intervals with Tukey’s post-test showing the difference between group
means for the padded simulation trials for the injector button. In Figure 15, there
is an overall summary of the ANOVA statistical data for the trigger injector
showing the F ratio of 10.0472 with two degrees of freedom.
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Figure 13. One-Way ANOVA data for trigger injector (TI)

Different trial groups comparison

Column means diff.
Trigger Injector- Padded (lbs) - Trigger Injector- Experimental (lbs)

Trigger Injector- Padded (lbs) - Trigger Injector-Validation (lbs)

Trigger Injector- Experimental (lbs) - Trigger Injector-Validation (lbs)
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Figure 14. One-Way ANOVA with Tukey’s Multiple Comparison
Confidence intervals for trigger injector
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Figure 15. One-Way ANOVA overall summary for trigger injector
Notice that the null hypothesis is that there is no difference in between means of
outcome forces for the trigger injector. The null hypothesis was rejected due to
significant difference between groups with a p-value less than 0.0001 and an F
ratio slightly greater than ten. On the Tukey’s multiple comparison test, the group
that is different is the Padding simulation trial, which is marked on Figure 15 as
*A. There was no difference in the post-test between validation and experimental
trials.

Results for Analytical Statistics
Reset Station
The results for the reset station were converted to logarithmic values to
achieve closeness to normality of data. Then, Kruskal Wallis test for nonparametric data was applied to the data. If the reader wants to see descriptions
of the gross value data, please refer to tables 2, 4 & 6. The mean and standard
deviation for the converted data are shown is table 11, with mean ranks of 67 for
group 1- validation trials, 69.13 for group 2-experimental trials and 62.75 for
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group 3, padded simulation. The Kruskal Wallis test displays an H-statistic of
0.2568 and a p-value of 0.8795 (see table 12), with no significant variation in the
median values.

The results on Table 13 for the reset station consisted of

normality tests to assess the distribution of the data. By using D'Agostino &
Pearson omnibus, Shapiro-Wilk normality test and Kolmogorov Smirnoff
normality was verified after converting the data to logarithmic values. In 3 out of
3 tests with an alpha set at 0.05, Dunn’s multiple comparison tests showed no
significant difference in between the mean rank or median obtained (see table
14).

Table 11

Kruskal-Wallis Test – Descriptive Statistic
Nonparametric ANOVA for Reset Station (RS)
*Logarithmic conversion of data

Descriptive Statistics
RS- Validation
(lbs)
Number of values
10
Minimum
1.077
25% Percentile
1.208
Median
1.370
75% Percentile
1.469
Maximum
1.523
Mean
1.344
Std. Deviation
0.1436
Std. Error of Mean
0.04542
Lower 95% CI
1.241
Upper 95% CI
1.446
Mean ranks
67.00

RS-Experimental
(lbs)
116
0.7287
1.228
1.363
1.488
1.918
1.357
0.2020
0.01876
1.320
1.394
69.13
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RS-Padded
(lbs)
10
1.013
1.149
1.386
1.439
1.518
1.313
0.1797
0.05681
1.184
1.441
62.75

Figures 16 a & b, show graphic distribution of the three groups with their
respective confidence intervals and the rank distribution for the data set of the
reset station. Values show a distribution of rank data points with similar
distribution of data and similar confidence intervals. Obviously the RS
experimental shows an abundant number of data ranks, due to the uneven
number of trials, in which the experimental group had n=116.

Table 12

Kruskal-Wallis Test – P-Value Summary
Nonparametric ANOVA for Reset Station (RS)
*Logarithmic conversion of data

Table Analyzed
Kruskal-Wallis test

One-way ANOVA data

P value

0.8795

Exact or approximate P value?

Approximate

P value summary

ns

Do the medians vary significantly (P < 0.05)
Number of groups

No
3

Kruskal-Wallis H- statistic
Data summary

0.2568

Number of treatments (columns)
Number of values (total)

3
136

39

Table 13

Kruskal-Wallis Test Normality Test
Nonparametric ANOVA for reset station (RS)
*Logarithmic conversion of data

Column
Reset StationReset StationStatistics
Validation (lbs)
Experimental (lbs)
Number of values
10
Minimum
1.077
25% Percentile
1.208
Median
1.370
75% Percentile
1.469
Maximum
1.523
D'Agostino & Pearson omnibus normality
test
K2
1.080
P value
0.5828
Passed normality test (alpha=0.05)?
Yes
P value summary
ns
Shapiro-Wilk normality test
W
0.9388
P value
0.5399
Passed normality test (alpha=0.05)?
Yes
P value summary
ns
KS Kolmogorov Smirnoff normality test
KS distance
0.1869
P value
0.2000
Passed normality test (alpha=0.05)?
Yes
P value summary
ns
Coefficient of variation
10.69%
Geometric mean
1.336
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Reset StationPadded (lbs)
116
10
0.7287
1.013
1.228
1.149
1.363
1.386
1.488
1.439
1.918
1.518

0.6791
0.7121
Yes
ns

1.327
0.5150
Yes
ns

0.9934
0.8587
Yes
ns

0.8938
0.1871
Yes
ns

0.05124
0.2000
Yes
ns
14.89%
1.342

0.2426
0.0980
Yes
ns
13.69%
1.301

Table 14

Kruskal-Wallis Test – Multiple Comparisons of mean ranks
Nonparametric ANOVA for reset station (RS)
*Logarithmic conversion of data

Multiple Comparison Test and Test Details
Alpha
0.05
Dunn's multiple
Mean Significant
Adjusted P
comparisons test
rank diff.
? ? Summary
Value
RS-Experimental (lbs) vs. RSValidation (lbs)
2.125
No
ns
> 0.9999
RS-Padded (lbs) vs. RSValidation (lbs)
-4.250
No
ns
> 0.9999
RS-Padded (lbs) vs. RSExperimental (lbs)
-6.375
No
ns
> 0.9999
Mean
Mean
Mean
Test details
rank 1
rank 2 rank diff.
RS-Experimental (lbs) vs. RSValidation (lbs)
69.13
67.00
2.125
RS-Padded (lbs) vs. RSValidation (lbs)
62.75
67.00
-4.250
RS-Padded (lbs) vs. RSExperimental (lbs)
62.75
69.13
-6.375
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logarithmic scale for non-parametric CI
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Figure 16 a & b. Kruskal Wallis One-Way ANOVA data for reset station
and ranks distribution

Figure 17.

ANOVA Kruskal Wallis (KW) Reset Station

Figure 17 shows an overall summary for the KW for the reset station. The null
hypothesis was that there is no difference in between the medians or mean ranks
of the three different groups. KW analysis shows no difference in between groups
with an H-statistic of 0.2568 and a p-value of 0.8795, which was not significant.
On Dunn’s multiple comparison test the letter B on the three groups describes no
difference for validation, experimental and padded trials. So the null hypothesis is
not rejected.
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Chapter V
Discussion
Many authors have discussed the needle free injector devices advantages
over needle devices with ESIP with regards to patient safety and elimination of
sharp hazards. This requires health care workers to learn and train how to use
new devices. Many of these recently acquired skills require human factors
engineering processes yet to be measured and determined when using practical
tools. Even though technology helps to simplify many of the steps in a procedure,
or gain efficacy over predecessor instruments, in many instances the ergonomics
in the design of new tools tend to be one of the last details taken into
consideration. The different components of the PharmaJet

TM

Stratis System will

be taken into consideration for the experimental product evaluation with the aim
of creating simple intervention or suggestions for both the manufactures and the
HCWs when using category 4 devices.
Even though many variables can come into play in any experiment, our
approach was to reduce threat to the internal validity of the study by creating an
elaborate protocol with more than 94 steps that will guide the researcher to
ensure repeatability and promote reproducibility for studies. Sophisticated
technological software and computers were employed to obtain precise
measurements and recordings of the forces involved in the compressive force
experiments for the trigger injector and reset station. Even though our initial
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intent was to create a formula that incorporated a summation of forces and
vectors involved during the whole sequence of steps involved in the use of the
device to provide a full injection, the complexity of the different maneuvers and
steps in the procedure impeded the elaboration of a formula to attain a precise
threshold limit value for the repetitive motion analysis. In spite of the complexity,
the measurement of compressive forces for the trigger injector button and
loading of the injector with a manual reset station were taken into consideration.
The implication of tensile forces for filling the syringes appeared to be of less
concern during the initial phase, due to the fact that any employer could
potentially buy the pre-filled needless syringes for injection. Another factor not
taken into account was the horizontal hand displacement forces when defeating
the blue tip safety feature. This was not considered important for the present
experiment because the safety feature for the injector was disabled when placing
it inside the wooden injector mount, but a factor to take into consideration for the
overall summation of forces. Our best approach was to come up with the
compressive dynamic force measurements across time, and subsequently
compare these measurements with 4 previously measured category 3 devices.
One of the challenges of human factors engineering is to evaluate different
workplace demands and contrast them to their functional capacities at work to
establish tolerance limit values (TLV). The potential psychophysics ergonomic
impact on HCWs with use of NFIDs was discussed to create appropriate
suggestions for manufacturer design and administrative considerations for future
usage implication for HCWs during and after procedure with repetitive motion
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involving fingertip push and pushing down with the upper extremity (Potvin,
2012).

Compressive forces for trigger injector button: The results for the descriptive
analysis were first preceded by a depiction of 136 graphs that were carefully
analyzed for shape and variability of the trigger injector. The compressive forces
were achieved by using a manual Andilog digital Com-Ten force gauge with an
external sensor that was in direct contact with the trigger injector button. As
shown in figure 11, the trigger injector displays a sample rate on the x-axis
across time vs. the dynamic force on the Y- axis. The graph shows three peak
spikes and an acute slump after the second spike. The sample rate was set at
1000 Hz and the measured forces in pounds. The first peak was generated when
the manual force gauge sensor area came in contact with the trigger injector
button. The second peak was generated to defeat the trigger mechanism
blocking the release of kinetic energy in the spring. The abrupt slump or downslope was generated when the trigger mechanism was physical defeated through
a pushing down an effort. The third peak was interesting because it was initially
thought to be the counter force generated by the spring device in the machine-tomachine interface. That led to the ideas of creating three different groups. The
first one will include the n=10 validation trials, the second n=116 experimental
trials, and the third group n=10 padding simulation trials. The padding simulation
trials were initially thought to make it more realistic when considering that the
human thumb has a soft-tissue pad before coming into contact with bone.
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The second potential advantage was to study the effect of adding a soft
tissue pad to help explain the phenomenon noticed on the third peak of the
trigger injector graph in Figure 11.
For our surprise, the peak effect did not disappear when the pad
simulation was added in case it was a counter force related with the spring
device. Instead, the peak only increased in width and height. That led us to
believe that is was not related to the counter force for the recoil spring device, but
the simple reaction time of the operator to react when pushing the TUP lever
back which was timed slightly under 0.2 seconds. That by itself increased the
average force of the trigger injector from 15.92 lbs. to 21.84 lbs. with a difference
of 6 lbs. of added force when adding a padded simulation or soft cushion
compared to the experimental trials.
After comparing the average forces obtained in all three-group trials for
the trigger injector, it was noticeable to appreciate a significant increase in
dynamic force required when adding the padded simulation, which resembles the
human-to-machine interference. Adding a rubber or soft cushion will not be a
recommended for comfort purposes, since it can potentially increase the force
required to defeat the trigger button.
That also accomplished the first part of the objectives and became an
average force measurement for further comparison to achieve the second set of
the objectives which consists of comparing the forces obtained to those required
to use with four previously analyzed retractable intramuscular syringes with
needles or category three devices.
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Triggering the injector button through thumb push

required considerable

effort in comparison to activating 4 retractable intramuscular syringes with
needles from our previous lab studies (Haiduven, 2011), the range of mean
forces were 3.63-17 lbs (16.19-77.53 N) for those syringes. The jet injector
required more force per effort than 2 (4.4 times for effort) syringes & similar to
other 2 syringes (0.9 times the effort) previously tested.
Compared to the best category three devices in terms of ergonomic
efficiency, there is almost a 12 lbs. (53.57 N) excess of compression force
implied in the action. This comparison might be considered a simple relative
value, but it becomes significant once it is compared against the NASA STD3000 203 which describes the thumb-finger tip strength with a limit of 13 lbs.(58
N) for momentary hold (2008) and the maximal voluntary forces for the finger tip
push of 56.6 N described by Potvin (2012). Since each effort time is short in the
order of 0.5-0.9 seconds, when plotting the value in Potvin’s equation it is above
the recommended level, with the advantage that there is no sustained effort.
The average maximal voluntary force for the experimental trials was 70.07
N, with a machine-to-machine interface, which can only be suggested to be of
higher value when using the real thumb soft tissue by 26.78 N. Even though the
trigger button was softer than prior the prior version of the NFIDs, it is above the
recommended value for maximal voluntary effort, which can be translated into
additional conflict once there is consideration of 480 minutes in an 8-hour period
with a potential of 480 shots or more during a day per operator use during
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massive vaccination campaigns. This outcome value of force measured could
potentially higher if taken into consideration that a skilled operator goes through
12 mini-steps of the procedure in less than 30 seconds. In that case maximal
achievable effort will have to cut the trigger button resistance by almost half of
the current value to around 35 N. Instead of limiting the number of thumb efforts
per cycle, the suggestion for the manufacturer will be either to further improve the
mechanism of the trigger injector or redesigning the trigger button to be used with
the palmar grasp of a squeezing mechanism consisting of pulling with 4 fingers
rather than pushing with the thumb. If not taken into consideration, that could
potentially result in hand and wrist pain secondary to strain of the metacarpal
joint or first ventral and dorsal compartment. Even though the time used per trial
averaged in between 3 to 4 minutes per trial due to strict adherence to the
protocol, no sustained effort for the critical measurements were done that would
affect the outcome. That is without considering the spurious finding that after
filling more than 50 syringes with tensile forces not being measured in the
experiment, two operators had pain and discomfort in the first metacarpal joint of
the dominant hand. Even though similar forces will be exerted when filling a
regular syringe, pre-filled syringes might be beneficial for HCWs’ prevention of
occupational hand injuries. In massive campaigns, it is recommended to have an
hour break in between and administrative controls consisting of rotating the
personnel activities, if the activities are segregated and encouraging frequent
recovery breaks to avoid repetitive motion injury.
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The one-way ANOVA for the trigger injector data with normal distribution
are described in Table 7 with their means and medians with standard deviations.
Additional information displays confidence intervals for the three groups of trials.
The p- value summary for the trigger injector data is shown on table 8, with
results consistent with an F ratio of 10.05 with a significant p-value below 0.0001
with significant differenced among the mean values of the three groups while
using 2,133 degrees of freedom. The null hypothesis of equality of the mean
force values was rejected, and a difference in between the groups was noted.
When comparing the three groups with Tukey’s multiple comparison post-test,
the padded simulation trials were significantly different than the validation and
experimental trials. Since there was no significant change in the shape for the
third peak of the trigger injector graph, and only an increase was seen in the
amount of force require to push which was 6 additional pounds, our simple
reasonable deduction will be that having the soft tissue of the thumb will add
force when measured in real human-to-machine interface. Even though that was
an additional suggestion by ergonomists to make it more real with respect to the
human body, that might potentially increase 26 N to the 71 N obtained for the
trigger injector button of machine-to-machine interface. Regardless of the prior,
the 71 N is already above the recommended level of 56.6 obtained by Potvin
(2012).
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Compressive forces for reset station: As shown in (Figures 9 a & b), the
experimental set up for force measurement of the reset station consists of a
small load sensor adhered to the arm of the reset station with a sample rate of
1,000/second for duration of 7 seconds, with subsequent data collection to Lab
View Software depicts a common graph tracing as seen in Figure 12. This graph
represented a typical tracing of a reset station in between a sample rate of 1000
Hz during a total period of seven seconds vs. force measured in pounds. There
was some interference in the first part of the tracing and then a sudden up-rise of
the slope with a variable peak followed by a sudden decrease in the force until it
plateaus to zero. That represents the push down arm exertion done by the R2
experimenter. The areas under the curve will be representative for the total
workload exerted by the individual without taking into account the initial artifact.
To evaluate the PharmaJet™ Needle-free reset station, with their respective
means, for each of the parameters studied the results were tabulated exhibiting
the average force, minimum force, maximum force, standard deviation and
range.
After statistically comparing the average forces obtained in all three-group
trials for the reset station, it was clear that there was no obvious difference in the
average forces for the three compared group trials. Comparing this value to
similar activities consisting of pushing down from prior literature, the maximal
volume effort for pushing down a hose is 130.2 N, which is a similar motion when
comparing the activation of the reset station (Adrews, 2008; Potvin, 2006). The
average was below that reported repetitive motion effort which is considered to
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be safe. Even though it is a simple and clever reloading device for the needleless injector, this action can potentially be eliminated completely out of the
summation equation if an automated device similar to the automatic staplers
commonly used for daily working tasks mechanisms was employed. That comes
into play especially during massive vaccination campaigns in which the R2s or
HCWs will have to push down constantly and potentially end up with pain in the
hand, wrist or upper arm strains. No pain was reported while using the device
because it was carefully placed in between waist level and below nipple level for
maximal protection of the R2 operator. If that simple principle is not respected,
the groups of muscles that will come into consideration above nipple level could
potentially induce excessive strain to the shoulder muscle group or lower back.
This was an additional force vector measurement when comparing to the effort to
category 3 devices. It adds time and effort when comparing to the simplicity of
the needle syringe devices. That is why this author recommends the optional
automated reload station for massive campaign vaccinations to avoid excess
repetitive motion.
In addition, the data for the reset station was not normally distributed, so it
was converted to logarithmic values to approximate normal distributed data, and
the three groups were subsequently analyzed to see any difference in the
medians or mean ranks among the groups which were evenly distributed Ranks
as seen in Figure 16 a and b. There was no statistical significance with a p-value
of 0.8795 and an H statistic of 0.2568. The null hypothesis cannot be rejected
and the Dunn’s multiple comparison-test showed no difference among the three
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groups. The mean ranks were 67, 69.13 and 62.75 for the three groups for the
validation, experimental and padded trials, respectively. We can conclude that
the reset station step for loading the injector is an easy step with a similar
learning distribution curve, but one that can be fully avoided if automatizing the
process is considered.
Additional comments will include additional consideration for the tensile
forces required to fill the syringes, since pain was elicited in two operators R1
and R2 after filling more than 50 syringes. The suggestions will be to buy prefilled syringes or implement a design with a spherical holder instead of a flat
circular holder to avoid the pinprick action that elicits pain. Instead, the action for
filling the syringe can be done with the first, second and third fingers. The
anatomical consideration was not added to the factor of the summation equation,
since the recommended suggestions by the manufacturer teach the usage of the
device in a neutral position. That assumption can be violated if the injection is not
given at the HCWs’ height in between the waist and the shoulders. The third
additional factor into consideration was that minimal amounts of air within the
syringe could lead to a wet shot or breaking of the needleless syringe. There was
only one wet shot during the learning phase, and it was observed under the
stereoscope with a cracked polycarbonate syringe with no missing pieces. That
provides a safety component for both the patient and the HCWs. The fourth
component was based on observations with regards to leakage of fluid while
loading the needleless syringe, and fluid in the cap with immediate vicinitysplatter. Even though it occurred in less than 5-10 % of the trials, the use of live
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vaccine components should be warranted and gloves and safety goggles were
considered wise when dealing with such tools, to avoid exposures of HCWs to
live vaccine

Strengths and limitations of the study: The strengths consisted of a strict
protocol to guard for internal validity. The R3 was double-checking all the steps
throughout. The recommendations and training from the manufacturer were
completely followed and practices with safe protocol of personal protective
equipment was ensured. Constant visual confirmation of injector alignment was
attained with the reset station. The fluid shot was simulated in ACF pad to notice
the effects on skin. The experimental study was conducted by a group of multidisciplinary team members and dynamic force measurement attained. The
author, R2, was the only one testing the device after thorough training, increasing
intra-rater reliability
The limitations were a delay in the data recorder, a small sensitive load
sensor area for evaluation of ergonomic issues in case the protocol is not
reproduced with precision in future studies, cost of the experiment, presence of
bubbles in syringes that might induce wet shots, increased time for visual
confirmation by R3 during the experiments, leveling and handle rotation, along
with the fact that strict adherence to the protocol might make a 30-45 second
trials into a 4 to 5 minutes strict trial per injection evaluated.
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Chapter VI
Conclusions
Triggering the injector and resetting the station required considerable
effort in comparison to activating 4 retractable intramuscular syringes with
needles from our previous studies. The range of mean forces was 3.63-17 lbs
(16.19-77.53 N) for those syringes with the trigger injector maximum voluntary
force of 71 N being above the recommend 56.6 N.
The jet injector required more force per effort than 2 (4.4x) syringes &
similar to other 2 syringes (0.9x) previously tested when considering the
compression forces related with the trigger injector (Haiduven et al., 2006; 2010).
Additional vector forces (displacement & gripping of reset station) could
increase the cumulative effort affecting different musculoskeletal components
when the whole components of the procedure are taken into account.
Suggestions for the manufacturer regarding design changes to facilitate
HCWs’ use of this device are warranted, since some of the summation forces
during the 12 mini-steps could be avoided to achieve a higher efficiency. This
information may be useful for health care facilities when choosing devices to
protect their workers from ergonomic injuries. Suggested automated reset
station, power grip with four fingers for trigger injector button and using prefilled
syringes or changing the pin-prick action to the use of three fingers.
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Future research implications with analytical sensor gloves to attain the full
effect of compression and tensile forces during the entire procedure will be ideal
to improve laboratory measures that will translate into clinical effectiveness to
make it more functionally appealing for its use for HCWs when compared to
simple category 3 devices.
This author wishes to emphasize that this work is not intended to discredit
the exhaustive effort of the manufacturer in question, but to aid in the fine-tuning
of a useful tool already showing clinical effectiveness throughout clinical trials
and revamping it to a state of the art tool that is safer and more efficient for use
by HCWs.

Suggestions for future research include but are not limited to the following:
Need to replicate with more than one HCW as operator, including shorter and
taller individuals and both genders; need to test with reset station moving versus
stationary, need to test with different orientations of the hand on the reset station,
need to use multi-sensor glove for dynamic measurements during a complete
duty cycle.
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Appendix A
IRB VA & USF-NIOSH ERC
Product evaluation under controlled laboratory conditions; the ethical
standards and training were highly taken into consideration prior starting the
analysis, by following requirements for the VA IRB and USF-NIOSH ERC to
maintain excellence in research standards with CITI search training completed.
The research project, which this experiment was part of, received approval
from the VA Office of Research & Development, Protocol #006142, “Laboratory
Evaluation of Sharps Devices to Prevent Blood Exposures and Ergonomic
Injuries in Healthcare Workers.”
The abstract initial date was 11/10/2011 with a protocol original proposal
on 06/09/2010. Approval to conduct this research was granted on 06/18/2012 by
Dr. William R. Gower, Hr., Ph.D. as the ACOS for Research Service as well as
the executive Secretary of the R&D Committee.
The proposal for this project was reviewed both scientifically and
administratively and fully approved by the Research and Development
Committee.
Documentation from the USF Health Sciences IRB was granted approval,
having both R&D, IRB, and Privacy Officer approvals, the project was approved
and subjects were allowed to be admitted to the study as stated in paragraph 2 of
the last page of the document of the current appendix.
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